Related Experiment Videos
[New aspects of defibrillator therapy]
J Brachmann1, T Hilbel, T Beyer
1Ruprechts-Karl-Universität, Abt. Innere Medizin III, Heidelberg.
Zeitschrift Fur Kardiologie
|January 1, 1996
Summary
Implantable cardioverter defibrillators (ICDs) treat malignant ventricular arrhythmias, but inappropriate shocks remain a challenge. Ongoing research focuses on improving discrimination algorithms and device technology to enhance patient outcomes and reduce costs.
Area of Science:
- Cardiology
- Biomedical Engineering
- Electrophysiology
Context:
- Implantable cardioverter defibrillators (ICDs) are the primary treatment for malignant, therapy-refractory ventricular arrhythmias.
- Continuous advancements in electrodes, shockforms, and device miniaturization have improved ICD efficacy and reduced implantation risks.
- Transvenous lead systems and biphasic shockforms have significantly lowered defibrillation thresholds and enabled subcutaneous leadless implants.
Purpose:
- To review the current state and future directions of implantable cardioverter defibrillator (ICD) therapy for ventricular arrhythmias.
- To highlight challenges in ICD therapy, particularly inappropriate shocks, and discuss emerging solutions.
- To explore potential expansions in ICD use and address cost limitations.
Summary:
- ICDs manage malignant ventricular arrhythmias via antitachycardia pacing, cardioversion, or defibrillation, with ongoing device and lead system optimization.
- A major challenge is inappropriate shocks from supraventricular tachyarrhythmias; solutions include enhanced memory storage, electrogram analysis, dual-chamber discrimination algorithms, and hemodynamic sensors.
- Future directions involve combining ICDs with other therapies like cardiomyoplasty and expanding ICD use in at-risk populations, with cost reduction as a goal.
Impact:
- Improved patient survival and quality of life through effective management of life-threatening ventricular arrhythmias.
- Reduced morbidity and mortality associated with ICD implantation and therapy delivery.
- Potential for wider adoption of ICD therapy with technological advancements and cost reductions, expanding access to sudden cardiac death prevention.